{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:23:42Z","timestamp":1772166222436,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T00:00:00Z","timestamp":1516060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T00:00:00Z","timestamp":1516060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1AI46995"],"award-info":[{"award-number":["RO1AI46995"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT104748MA"],"award-info":[{"award-number":["WT104748MA"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12977-018-0390-9","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T07:37:29Z","timestamp":1516088249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Rapid HIV disease progression following superinfection in an HLA-B*27:05\/B*57:01-positive transmission recipient"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6528-6471","authenticated-orcid":false,"given":"Jacqui","family":"Brener","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Gall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Batorsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Lavandier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrissy","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Dsouza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver G.","family":"Pybus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kellam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippa C.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J. R.","family":"Goulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,16]]},"reference":[{"key":"390_CR1","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1126\/science.1195271","volume":"330","author":"F Pereyra","year":"2010","unstructured":"Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PIW, Walker BD, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (80-). 2010;330:1551\u20137.","journal-title":"Science (80-)"},{"key":"390_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.immuni.2012.09.005","volume":"37","author":"PJR Goulder","year":"2012","unstructured":"Goulder PJR, Walker BD. HIV and HLA class I: an evolving relationship. Immunity. 2012;37:426\u201340.","journal-title":"Immunity"},{"key":"390_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nm1520","volume":"13","author":"P Kiepiela","year":"2007","unstructured":"Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med. 2007;13:46\u201353.","journal-title":"Nat Med"},{"key":"390_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature14053","volume":"517","author":"K Deng","year":"2015","unstructured":"Deng K, Pertea M, Rongvaux A, Wang L, Durand CM, Ghiaur G, et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature. 2015;517:381\u20135.","journal-title":"Nature"},{"key":"390_CR5","doi-asserted-by":"publisher","first-page":"10543","DOI":"10.1128\/JVI.00793-10","volume":"84","author":"RP Payne","year":"2010","unstructured":"Payne RP, Kl\u00f8verpris H, Sacha JB, Brumme Z, Brumme C, Buus S, et al. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells. J Virol. 2010;84:10543\u201357.","journal-title":"J Virol"},{"key":"390_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12977-015-0179-z","volume":"12","author":"J Brener","year":"2015","unstructured":"Brener J, Gall A, Batorsky R, Riddell L, Buus S, Leitman E, et al. Disease progression despite protective HLA expression in an HIV-infected transmission pair. Retrovirology. 2015;12:55.","journal-title":"Retrovirology"},{"key":"390_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.humimm.2007.01.014","volume":"68","author":"P Cano","year":"2007","unstructured":"Cano P, Klitz W, Mack SJ, Maiers M, Marsh SGE, Noreen H, et al. Common and well-documented HLA alleles: report of the ad-hoc committee of the American Society for Histocompatiblity and Immunogenetics. Hum Immunol. 2007;68:392\u2013417.","journal-title":"Hum Immunol"},{"key":"390_CR8","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1128\/JVI.77.3.2081-2092.2003","volume":"77","author":"MM Addo","year":"2003","unstructured":"Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, Strick D, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol. 2003;77:2081\u201392.","journal-title":"J Virol"},{"key":"390_CR9","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1128\/JCM.01516-12","volume":"50","author":"A Gall","year":"2012","unstructured":"Gall A, Ferns B, Morris C, Watson S, Cotten M, Robinson M, et al. Universal amplification, next-generation sequencing and assembly of HIV-1 genomes. J Clin Microbiol. 2012;50:3838\u201344.","journal-title":"J Clin Microbiol"},{"key":"390_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature07517","volume":"456","author":"DR Bentley","year":"2008","unstructured":"Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature. 2008;456:53\u20139.","journal-title":"Nature"},{"key":"390_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/genomeA.01254-13","volume":"2","author":"A Gall","year":"2014","unstructured":"Gall A, Morris C, Kellam P. Complete genome sequence of the WHO international standard for HIV-1 RNA determined by deep sequencing. Genome Announc. 2014;2:10\u20131.","journal-title":"Genome Announc"},{"key":"390_CR12","doi-asserted-by":"publisher","first-page":"e1002529","DOI":"10.1371\/journal.ppat.1002529","volume":"8","author":"MR Henn","year":"2012","unstructured":"Henn MR, Boutwell CL, Charlebois P, Lennon NJ, Power K, Macalalad AR, et al. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog. 2012;8:e1002529.","journal-title":"PLoS Pathog"},{"key":"390_CR13","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/gb-2004-5-2-r12","volume":"5","author":"S Kurtz","year":"2004","unstructured":"Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, Antonescu C, et al. Versatile and open software for comparing large genomes. Genome Biol. 2004;5:R12.","journal-title":"Genome Biol"},{"key":"390_CR14","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/molbev\/msn083","volume":"25","author":"D Posada","year":"2008","unstructured":"Posada D. jModelTest: phylogenetic model averaging. Mol Biol Evol. 2008;25:1253\u20136.","journal-title":"Mol Biol Evol"},{"key":"390_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ve\/vev003","volume":"1","author":"DP Martin","year":"2015","unstructured":"Martin DP, Murrell B, Golden M, Khoosal A, Muhire B. RDP4: detection and analysis of recombination patterns in virus genomes. Virus Evol. 2015;1:1.","journal-title":"Virus Evol"},{"key":"390_CR16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/JVI.73.1.152-160.1999","volume":"73","author":"KS Lole","year":"1999","unstructured":"Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73:152\u201360.","journal-title":"J Virol"},{"key":"390_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jviromet.2005.08.003","volume":"131","author":"M Brockman","year":"2006","unstructured":"Brockman M, Tanzi GO, Walker BD, Allen TM. Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry. J Virol Methods. 2006;131:134\u201342.","journal-title":"J Virol Methods"},{"key":"390_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1128\/JVI.01471-08","volume":"83","author":"T Miura","year":"2009","unstructured":"Miura T, Brockman MA, Brumme ZL, Brumme CJ, Pereyra F, Trocha A, et al. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1. J Virol. 2009;83:140\u20139.","journal-title":"J Virol"},{"key":"390_CR19","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1073\/pnas.94.9.4653","volume":"94","author":"A Gervaix","year":"1997","unstructured":"Gervaix A, West D, Leoni LM, Richman DD, Wong-Staal F, Corbeil J. A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc Natl Acad Sci. 1997;94:4653\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"390_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0198-8859(98)00113-X","volume":"60","author":"H Tomiyama","year":"1999","unstructured":"Tomiyama H, Sakaguchi T, Miwa K, Oka S, Iwamoto A, Kaneko Y, et al. Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules. Hum Immunol. 1999;60:177\u201386.","journal-title":"Hum Immunol"},{"key":"390_CR21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nature07746","volume":"458","author":"Y Kawashima","year":"2009","unstructured":"Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, Addo M, et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature. 2009;458:641\u20135.","journal-title":"Nature"},{"key":"390_CR22","doi-asserted-by":"publisher","first-page":"13202","DOI":"10.1128\/JVI.01998-12","volume":"86","author":"JM Carlson","year":"2012","unstructured":"Carlson JM, Brumme CJ, Martin E, Listgarten J, Brockman M, Le AQ, et al. Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1. J Virol. 2012;86:13202\u201316.","journal-title":"J Virol"},{"key":"390_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2014.05.018","volume":"61","author":"PC Matthews","year":"2014","unstructured":"Matthews PC, Geretti AM, Goulder PJR, Klenerman P. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. J Clin Virol. 2014;61:1\u201314.","journal-title":"J Clin Virol"},{"key":"390_CR24","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1128\/JVI.80.7.3617-3623.2006","volume":"80","author":"J Martinez-picado","year":"2006","unstructured":"Martinez-picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, Chetty S, et al. Fitness cost of escape mutations in p24 gag in association with control of human immunodeficiency virus type 1. J Virol. 2006;80:3617\u201323.","journal-title":"J Virol"},{"key":"390_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nm992","volume":"10","author":"AJ Leslie","year":"2004","unstructured":"Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med. 2004;10:282\u20139.","journal-title":"Nat Med"},{"key":"390_CR26","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1084\/jem.20081984","volume":"206","author":"H Crawford","year":"2009","unstructured":"Crawford H, Lumm W, Leslie A, Schaefer M, Boeras D, Prado JG, et al. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J Exp Med. 2009;206:909\u201321.","journal-title":"J Exp Med"},{"key":"390_CR27","doi-asserted-by":"publisher","first-page":"12382","DOI":"10.1128\/JVI.01543-07","volume":"81","author":"A Schneidewind","year":"2007","unstructured":"Schneidewind A, Brockman MA, Yang R, Adam RI, Li B, Le Gall S, et al. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol. 2007;81:12382\u201393.","journal-title":"J Virol"},{"key":"390_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1084\/jem.20090365","volume":"206","author":"N Goonetilleke","year":"2009","unstructured":"Goonetilleke N, Liu MKP, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov VV, et al. The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med. 2009;206:1253\u201372.","journal-title":"J Exp Med"},{"key":"390_CR29","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1128\/JVI.01108-08","volume":"83","author":"A Schneidewind","year":"2009","unstructured":"Schneidewind A, Brumme ZL, Brumme CJ, Power KA, Reyor LL, O\u2019Sullivan K, et al. Transmission and long-term stability of compensated CD8 escape mutations. J Virol. 2009;83:3993\u20137.","journal-title":"J Virol"},{"key":"390_CR30","doi-asserted-by":"publisher","first-page":"8346","DOI":"10.1128\/JVI.00465-07","volume":"81","author":"H Crawford","year":"2007","unstructured":"Crawford H, Prado JG, Leslie A, Hu\u00e9 S, Honeyborne I, Reddy S, et al. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J Virol. 2007;81:8346\u201351.","journal-title":"J Virol"},{"key":"390_CR31","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1128\/JVI.06682-11","volume":"86","author":"JK Wright","year":"2012","unstructured":"Wright JK, Naidoo VL, Brumme ZL, Prince JL, Claiborne DT, Goulder PJR, et al. Impact of HLA-B*81-associated mutations in HIV-1 gag on viral replication capacity. J Virol. 2012;86:3193\u20139.","journal-title":"J Virol"},{"key":"390_CR32","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1084\/jem.20070784","volume":"204","author":"JR Almeida","year":"2007","unstructured":"Almeida JR, Price D, Papagno L, Arkoub ZA, Sauce D, Bornstein E, et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med. 2007;204:2473\u201385.","journal-title":"J Exp Med"},{"key":"390_CR33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/ni.2342","volume":"13","author":"H Chen","year":"2012","unstructured":"Chen H, Ndhlovu ZM, Liu D, Porter LC, Fang JW, Darko S, et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat Immunol. 2012;13:691\u2013700.","journal-title":"Nat Immunol"},{"key":"390_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1086\/526786","volume":"197","author":"F Pereyra","year":"2008","unstructured":"Pereyra F, Addo MM, Kaufmann DE, Liu Y, Miura T, Rathod A, et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis. 2008;197:563\u201371.","journal-title":"J Infect Dis"},{"key":"390_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.1232685","volume":"340","author":"R Apps","year":"2013","unstructured":"Apps R, Qi Y, Carlson JM, Chen H, Gao X, Thomas R, et al. Influence of HLA-C expression level on HIV control. Science. 2013;340:87\u201391.","journal-title":"Science"},{"key":"390_CR36","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ng2035","volume":"39","author":"MP Martin","year":"2007","unstructured":"Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet. 2007;39:733\u201340.","journal-title":"Nat Genet"},{"key":"390_CR37","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1126\/science.273.5283.1856","volume":"273","author":"M Dean","year":"1996","unstructured":"Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science (80-). 1996;273:1856\u201362.","journal-title":"Science (80-)"},{"key":"390_CR38","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nm.4100","volume":"22","author":"JM Carlson","year":"2016","unstructured":"Carlson JM, Du VY, Pfeifer N, Bansal A, Tan VYF, Power K, et al. Impact of pre-adapted HIV transmission. Nat Med. 2016;22:606\u201313.","journal-title":"Nat Med"},{"key":"390_CR39","doi-asserted-by":"crossref","first-page":"E1480","DOI":"10.1073\/pnas.1421607112","volume":"112","author":"DT Claiborne","year":"2015","unstructured":"Claiborne DT, Prince JL, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci. 2015;112:E1480\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"390_CR40","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1084\/jem.20072457","volume":"205","author":"PA Goepfert","year":"2008","unstructured":"Goepfert PA, Lumm W, Farmer P, Matthews P, Prendergast A, Carlson JM, et al. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med. 2008;205:1009\u201317.","journal-title":"J Exp Med"},{"key":"390_CR41","doi-asserted-by":"publisher","first-page":"e1003041","DOI":"10.1371\/journal.ppat.1003041","volume":"8","author":"JL Prince","year":"2012","unstructured":"Prince JL, Claiborne DT, Carlson JM, Schaefer M, Yu T, Lahki S, et al. Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis. PLoS Pathog. 2012;8:e1003041.","journal-title":"PLoS Pathog"},{"key":"390_CR42","doi-asserted-by":"publisher","first-page":"11407","DOI":"10.1128\/JVI.01211-09","volume":"83","author":"VD Gonzalez","year":"2009","unstructured":"Gonzalez VD, Falconer K, Blom KG, Reichard O, Morn B, Laursen AL, et al. High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment. J Virol. 2009;83:11407\u201311.","journal-title":"J Virol"},{"key":"390_CR43","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1056\/NEJMoa040842","volume":"351","author":"FJ Torriani","year":"2004","unstructured":"Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-Garcia J, Lazzarin A, et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med. 2004;351:438\u201350.","journal-title":"N Engl J Med"},{"key":"390_CR44","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature03113","volume":"432","author":"P Kiepiela","year":"2004","unstructured":"Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature. 2004;432:769\u201375.","journal-title":"Nature"},{"key":"390_CR45","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1128\/JVI.02356-07","volume":"82","author":"A Schneidewind","year":"2008","unstructured":"Schneidewind A, Brockman MA, Sidney J, Wang YE, Chen H, Suscovich TJ, et al. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid. J Virol. 2008;82:5594\u2013605.","journal-title":"J Virol"},{"key":"390_CR46","doi-asserted-by":"publisher","first-page":"e12463","DOI":"10.1371\/journal.pone.0012463","volume":"5","author":"M Rolland","year":"2010","unstructured":"Rolland M, Carlson JM, Manocheewa S, Swain JV, Lanxon-Cookson E, Deng W, et al. Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics. PLoS ONE. 2010;5:e12463.","journal-title":"PLoS ONE"},{"key":"390_CR47","doi-asserted-by":"publisher","first-page":"11937","DOI":"10.1128\/JVI.01086-10","volume":"84","author":"MA Brockman","year":"2010","unstructured":"Brockman MA, Brumme ZL, Brumme CJ, Miura T, Sela J, Rosato PC, et al. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J Virol. 2010;84:11937\u201349.","journal-title":"J Virol"},{"key":"390_CR48","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1128\/JVI.01879-10","volume":"85","author":"H Crawford","year":"2011","unstructured":"Crawford H, Matthews PC, Schaefer M, Carlson JM, Leslie A, Kilembe W, et al. The hypervariable HIV-1 capsid protein residues comprise HLA-driven CD8+ T-cell escape mutations and covarying HLA-independent polymorphisms. J Virol. 2011;85:1384\u201390.","journal-title":"J Virol"},{"key":"390_CR49","doi-asserted-by":"publisher","first-page":"e19018","DOI":"10.1371\/journal.pone.0019018","volume":"6","author":"KHG Huang","year":"2011","unstructured":"Huang KHG, Goedhals D, Carlson JM, Brockman MA, Mishra S, Brumme ZL, et al. Progression to AIDS in South Africa is associated with both reverting and compensatory viral mutations. PLoS ONE. 2011;6:e19018.","journal-title":"PLoS ONE"},{"key":"390_CR50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12977-016-0300-y","volume":"13","author":"M-H Tsai","year":"2016","unstructured":"Tsai M-H, Muenchhoff M, Adland E, Carlqvist A, Roider J, Cole DK, et al. Paediatric non-progression following grandmother-to-child HIV transmission. Retrovirology. 2016;13:65.","journal-title":"Retrovirology"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-018-0390-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12977-018-0390-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-018-0390-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T05:45:40Z","timestamp":1589521540000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-018-0390-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,16]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1186\/s12977-018-0390-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732500556.793547581","asserted-by":"object"}]},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,16]]},"assertion":[{"value":"21 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}